Latest Articles

Publication Date
Non-Hormonal Strategies in Endometriosis: Targets with Future Clinical Potential.

Endometriosis is a chronic gynecological pathology marked by the aberrant proliferation of tissue analogous to the endometrial lining outside the uterine cavity. This disorder frequently engenders persistent pelvic discomfort, infertility, …

Published: July 17, 2025, midnight
Role of AMP-Activated Protein Kinase (AMPK) in Female Reproduction: A Review.

The adenosine monophosphate (AMP)-activated protein kinase (AMPK) signalling pathway regulates cell metabolism, inflammation and the immune response. This signalling pathway is essential for maintaining reproductive homeostasis and influencing steroidogenesis, implantation, …

Published: July 16, 2025, midnight
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Insider Monkey

Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Insider Monkey

Published: July 10, 2025, 3:21 p.m.
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo

Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program Yahoo

Published: July 10, 2025, 3:13 p.m.
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure - geneonline.com

Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure geneonline.com

Published: July 10, 2025, 8:10 a.m.
Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).

Immunological factors appear to play an important role in the development of endometriosis, as evidenced by the aberrant functioning of immune cells often observed in affected women. Although endometriosis is …

Published: July 10, 2025, midnight
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MSN

Organon to halt development of endometriosis pain drug after mid-stage trial failure MSN

Published: July 3, 2025, 10:49 p.m.
Organon abandons endometriosis pain drug development after trial failure - MSN

Organon abandons endometriosis pain drug development after trial failure MSN

Published: July 3, 2025, 4:01 p.m.
Organon drops OG-6219 development following trial miss - The Pharma Letter

Organon drops OG-6219 development following trial miss The Pharma Letter

Published: July 3, 2025, 10:55 a.m.
Karolinska Development receives update from Organon concerning OG-6219 - The Manila Times

Karolinska Development receives update from Organon concerning OG-6219 The Manila Times

Published: July 3, 2025, 5:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!